Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...

S ometimes writing your ideas in your notes isn't enough. That’s when you need to get your thoughts out of your head and onto ...

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps ...

For decades, nuclear physicists believed that "Islands of Inversion"—regions where the normal rules of nuclear structure ...

Structure Therapeutics said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company's shares more than 140% higher.

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.

An international research team may have found an explanation for seismic anomalies, the noticeable deviations in the behavior of earthquake waves, in Earth's inner core.

Y-12's Building 9206 downgraded from a nuclear to a radiologically contaminated site, setting the stage for demolition.